Private company

DYNAVAX TECHNOLOGIES CORP

American pharmaceutical preparations company based in Berkeley.

Last updated Oct 18, 2026.

Overview

  • IndustryPharmaceutical Preparations
  • HeadquartersBerkeley, United States
  • Incorporated inDE2
  • Business address2100 Powell Street, Suite 720, Emeryville, Ca 946082
  • Filer categoryLarge accelerated filer2

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2024

-1.5%Operating margin3
9.9%Net margin3
19.4%Revenue growth, 20243
4.6%Return on equity3
$60.2MFree cash flow3

Where the money goes

Where each dollar of revenue went, fiscal 2024

  • Research and development22¢$61.5M
  • Selling, general and admin61¢$170.4M
  • Other costs5¢$14.5M
  • Income tax1¢$3.5M
  • Profit10¢$27.3M

Out of $277.2M in revenue.3

Where each dollar of operating cash went, fiscal 2024

  • Capital spending6¢$6.4M
  • Share buybacks94¢$100.0M

Out of $66.5M of cash from operations. Spending exceeded cash from operations; the rest came from savings or borrowing.3

Financial statements

Revenue45673$277.2M in 2024+3282% since 2018
0$200.0M$400.0M$600.0M$800.0M2018: $8.2M$8.2M20182019: $35.2M$35.2M2019+330%2020: $46.6M$46.6M2020+32%2021: $439.4M$439.4M2021+844%2022: $722.7M$722.7M2022+64%2023: $232.3M$232.3M2023−68%2024: $277.2M$277.2M2024+19%
Operating income45673-$4.1M in 2024−97% since 2018
-$200.0M0$200.0M$400.0M2018: -$153.3M-$153.3M20182019: -$134.8M-$134.8M2019−12%2020: -$68.4M-$68.4M2020−49%2021: $134.5M$134.5M20212022: $283.5M$283.5M2022+111%2023: -$37.0M-$37.0M20232024: -$4.1M-$4.1M2024−89%
Net income45673$27.3M in 2024
-$200.0M0$200.0M$400.0M2018: -$158.9M-$158.9M20182019: -$152.6M-$152.6M2019−4%2020: -$75.2M-$75.2M2020−51%2021: $76.7M$76.7M20212022: $293.2M$293.2M2022+282%2023: -$6.4M-$6.4M20232024: $27.3M$27.3M2024
Fiscal year2018201920202021202220232024
Revenue$8.2M4$35.2M5$46.6M6$439.4M7$722.7M3$232.3M3$277.2M3
Research and development$75.0M4$62.3M5$28.6M6$32.2M7$46.6M3$54.9M3$61.5M3
Selling, general and admin$64.8M4$75.0M5$79.3M6$100.2M7$131.4M3$152.9M3$170.4M3
Operating income-$153.3M4-$134.8M5-$68.4M6$134.5M7$283.5M3-$37.0M3-$4.1M3
Interest$9.3M4$17.0M5$19.1M6$11.2M7$6.7M7$6.8M7
Income tax$04$05$06$808.0K7$1.1M3$2.0M3$3.5M3
Net income-$158.9M4-$152.6M5-$75.2M6$76.7M7$293.2M3-$6.4M3$27.3M3
Earnings per share-$2.554-$2.165-$0.756$0.627$2.323-$0.053$0.213
Earnings per share (diluted)-$2.554-$2.165-$0.786$0.577$1.973-$0.053$0.203

Compare DYNAVAX TECHNOLOGIES CORP with another company

Leadership

Who has led DYNAVAX TECHNOLOGIES CORP, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Dino Dina2006–2012
  2. Zbigniew Janowicz2009–2012
  3. Ryan Spencer2019–now

President

  1. Dino Dina2006–2010
  2. J. Tyler Martin2010–2012
  3. David F. Novack2019–now

Chief financial officer

  1. Deborah A. Smeltzer2006–2009
  2. Kelly Macdonald2021–now

Chief operating officer

  1. David F. Novack2019–now
2010201520202025
Board members and other officers (42)

Timeline

  1. Dec 17, 2019New chief executive Ryan Spencer becomes CEO12
  2. Mar 12, 2009New chief executive Zbigniew Janowicz becomes CEO13
  3. Feb 27, 2006New chief executive Dino Dina becomes CEO14
  4. Nov 6, 2000Founded DYNAVAX TECHNOLOGIES CORP is founded59

Filings

361 filings to the SEC since October 2021: 4 annual reports, 13 quarterly reports, 47 major events, 160 insider forms, 26 large holders, 111 other. The latest 20:

  1. Feb 20, 202615-12G EDGAR
  2. Feb 13, 2026EFFECT EDGAR
  3. Feb 11, 20264 EDGAR
  4. Feb 11, 2026SCHEDULE 13G/A EDGAR
  5. Feb 10, 20264 EDGAR
  6. Feb 10, 20264 EDGAR
  7. Feb 10, 20264 EDGAR
  8. Feb 10, 20264 EDGAR
  9. Feb 10, 20264 EDGAR
  10. Feb 10, 20264 EDGAR
  11. Feb 10, 20264 EDGAR
  12. Feb 10, 20264 EDGAR
  13. Feb 10, 20264 EDGAR
  14. Feb 10, 202625-NSE EDGAR
  15. Feb 10, 20264 EDGAR
  16. Feb 10, 20264 EDGAR
  17. Feb 10, 2026S-8 POS EDGAR
  18. Feb 10, 2026S-8 POS EDGAR
  19. Feb 10, 2026S-8 POS EDGAR
  20. Feb 10, 2026S-8 POS EDGAR

The 361 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last three years, summarized. The full record is on SEC EDGAR.

Insider trades and holders

Large holders

Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 26 such filings since October 2021, the latest 10:

  1. Feb 11, 2026SCHEDULE 13G/A
  2. Aug 25, 2025SCHEDULE 13G/A
  3. Feb 19, 2025SCHEDULE 13D/A
  4. Feb 14, 2025SCHEDULE 13G/A
  5. Nov 14, 2024SC 13G
  6. Nov 12, 2024SC 13G/A
  7. Oct 24, 2024SC 13D/A
  8. Oct 18, 2024SC 13G/A
  9. Oct 16, 2024SC 13G/A
  10. Sep 16, 2024SC 13D

From Forms 4 and Schedules 13D and 13G filed with the SEC.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59